Jeffrey H. Lawrence

A 17‐Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy

P. Febbo, S. Raman, D. Elashoff, 2018, The Journal of urology.

The Impact of a Biopsy Based 17‐Gene Genomic Prostate Score on Treatment Recommendations in Men with Newly Diagnosed Clinically Prostate Cancer Who are Candidates for Active Surveillance

P. Febbo, K. Badani, M. Rothberg, 2015, Urology practice.